Concepedia
Statistics
Publications
8
Citations
417
H-Index
Active since
2017
Affiliations
United States Food and Drug Administration(Current)
University of Liverpool
KU Leuven
Center for Drug Evaluation and Research
Eli Lilly (United States)
Gerri Baer is an author at United States Food and Drug Administration specializing in pharmacy, pediatrics, and pediatric pharmacology.
Publications per year
2017–2022
Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs
John N. van den Anker, Susan McCune, Pieter Annaert et al. · Pharmaceutics · 2020 · 97 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +17
Scientific, ethical, and legal considerations for the inclusion of pregnant people in clinical trials
Catherine Sewell, Sarah M. Sheehan, Mira S. Gill et al. · American Journal of Obstetrics and Gynecology · 2022 · 76 citations · Full text
Medicine, Maternal Health, Obstetrics +16
Development of a neonatal adverse event severity scale through a Delphi consensus approach
Thomas Salaets, M. Turner, Mary B. Short et al. · Archives of Disease in Childhood · 2019 · 70 citations · Full text
Medicine, Pediatrics, Neonatal Health +10
Necrotizing Enterocolitis: Using Regulatory Science and Drug Development to Improve Outcomes
Michael S. Caplan, Mark A. Underwood, Neena Modi et al. · The Journal of Pediatrics · 2019 · 55 citations · Full text
Pharmacy, Infectious Diseases, Internal Medicine +11
Challenges and strategies to facilitate formulation development of pediatric drug products: Safety qualification of excipients
Lorrene A. Buckley, Smita Salunke, Karen Thompson et al. · International Journal of Pharmaceutics · 2017 · 41 citations
Pharmacy, Pediatrics, Pharmaceutics +16
1–5 of 8